TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporated TDG, which is scheduled to release quarterly earnings today.

TransDigm Group is expected to report fiscal 2024 first quarter earnings before the opening bell on Feb. 8, 2024. Analysts expect the company to report quarterly earnings at $6.41 per share, up from year-ago earnings of $4.58 per share. The company is projected to post revenue of 1.68 billion for the recent quarter.

Brian Belski of BMO Capital Markets said he loves Sonos, Inc. SONO.

Sonos reported better-than-expected first-quarter financial results. The company posted adjusted earnings of 84 cents per share, beating market estimates of 39 cents per share. Its quarterly sales came in at $612.87 million, topping expectations of $587.20 million.

Don’t forget to check out our premarket coverage here

Karen Firestone of Aureus Asset Management picked Thermo Fisher Scientific Inc. TMO.

Thermo Fisher Scientific posted a fourth-quarter revenue of $10.89 billion, down 5% year-on-year (Y/Y), beating the consensus of $10.73 billion.

Joe Terranova of Virtus Investment Partners named West Pharmaceutical Services, Inc. WST as his final trade.

West Pharmaceutical Services is expected to release fourth-quarter and full-year 2023 financial results before the opening bell on Feb. 15, 2024.

Price Action:

• TransDigm shares gained 0.6% to close at $1,147.01 on Wednesday.
• Sonos shares jumped 17.1% to settle at $19.28 during Wednesday’s session.
• Shares of Thermo Fisher Scientific fell 1.4% to settle at $552.31 on Wednesday.
• West Pharmaceutical shares gained 3.7% to close at $413.00 on Wednesday.

Check This Out: Jim Cramer Says This Real Estate Stock Is 'Done Going Down, That's A Gutsy Call By Me'

Image: Shutterstock